Hepatitis C Infection Screening and Management in Opioid Use Epidemics in the United States - 29/10/18

Doi : 10.1016/j.amjmed.2018.06.003

Xibei Liu, MD ^a, Jay Shen, PhD ^b, Pearl Kim, PhDc ^b, Seong-min Park, PhD ^c, Sungyoun Chun, PhD ^c, Jen-Jung Pan, MD, PhD ^d, Mohamed Azab, MD ^e, Haneul Choi ^f, Hyeyoung Yeom, MD ^b, Yong-Jae Lee, MD ^g, Ji Won Yoo, MD ^e,^⁎
^a Department of Medicine University of Arizona College of Medicine Tucson
^b School of Community Health Sciences
^c Department of Criminal Justice Greenspun College of Urban Affairs University of Nevada Las Vegas
^d Division of Gastroenterology and Hepatology University of Arizona College of Medicine Tucson
^e Department of Internal Medicine
^f Honors College University of Nevada Las Vegas
^g Department of Family Medicine Yonsei University College of Medicine Seoul, Korea

^⁎Requests for reprints should be addressed to Ji Won Yoo, MD, Department of Internal Medicine, University of Nevada Las Vegas School of Medicine, 1701 W Charleston Boulevard, #230, Las Vegas, NV 89102.Department of Internal MedicineUniversity of Nevada Las Vegas School of Medicine1701 W Charleston Boulevard, #230Las VegasNV89102

Le texte complet de cet article est disponible en PDF.

Plan

Acute Hepatitis C and Heroin Use Epidemics in the United States

Unequal Access to Cost-Effective Direct-Acting Antiviral Therapy in the United States

Hepatitis C Screening Strategies in the United States

Substance Use Disorder and Hepatitis C Treatment Under Health Care Reform

Marijuana Legalization Laws and the Opioid Epidemic

“Call to Action” for the Revision of Hepatitis C Screening Recommendations

	Funding: None.
	Conflict of Interest: None.
	Authorship: Study concept and design: XL, SP, and JS. Literature search, data collection/interpretation, and art work creation: PK, SC, HC, and HY. Manuscript: Acute Hepatitis C and Heroin Use Epidemics in the United States section—XL, JS, PK, SC; Unequal Access to Cost-Effective Direct-Acting Antiviral Therapy in the United States section—SP, Y-JL, J-JP, MA; Hepatitis C Screening Strategies in the United States section—Y-JL, MA, HC, HY; Substance Use Disorder and Hepatitis C Under Health Care Reform section—JS, PK, SP, JWY; “Call to Action” for the Revision of Hepatitis C Screening Recommendations section—JS, PK, SP, SC, JWY. XL and JS contributed equally as first authors. All authors discussed and agreed with the final version of the manuscript.